Accedi

Hui Xie

Tianjin Institute of Urology

The Second Hospital of Tianjin Medical University

BIOGRAPHY

Hui Xie has not added Biography.

If you are Hui Xie and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.

Clinica chimica acta; international journal of clinical chemistry Dec, 2017 | Pubmed ID: 29080691

Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals.

Cancer management and research , 2017 | Pubmed ID: 29200888

Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis.

Oncotarget Nov, 2017 | Pubmed ID: 29254251

Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals.

Clinical and experimental medicine May, 2018 | Pubmed ID: 29362922

Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.

Clinica chimica acta; international journal of clinical chemistry May, 2018 | Pubmed ID: 29462592

Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma.

Clinica chimica acta; international journal of clinical chemistry Nov, 2018 | Pubmed ID: 30006290

Neutrophil-lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis.

Cancer management and research , 2018 | Pubmed ID: 30271208

High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients.

Medical science monitor : international medical journal of experimental and clinical research Nov, 2018 | Pubmed ID: 30427826

Correction: Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis.

Oncotarget 11, 2018 | Pubmed ID: 30555638

Development and validation of CT imaging-based preoperative nomogram in the prediction of unfavorable high-grade small renal masses.

Cancer management and research , 2019 | Pubmed ID: 31576175

Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer.

Vaccines Jul, 2021 | Pubmed ID: 34358202

Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer.

Frontiers in genetics , 2022 | Pubmed ID: 35559045

INSTITUTIONS

The Second Hospital of Tianjin Medical University

JOVE ARTICLES

Economical and Efficient Protocol for Isolating and Culturing Bone Marrow-derived Dendritic Cells from Mice

Huiqin Tang^*,1,

Hui Xie^*,1,

Zhun Wang¹,

Shuanghe Peng²,

Wenli Ni¹,

Linpei Guo³

¹Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University,

²Department of Pathology, The Second Hospital of Tianjin Medical University,

³Department of Urology, The Affiliated Wuxi No.2 People’s Hospital of Nanjing Medical University

Immunology and Infection

Riservatezza

Condizioni di utilizzo

Politiche

Contattaci

SUGGERISCI JOVE ALLA BIBLIOTECA

Newsletter di JoVE

Ricerca

JoVE Journal
Raccolta di metodi
JoVE Encyclopedia of Experiments
Archivio

Didattica

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Sportello unico per docenti
Faculty Site

Autori

Panoramica
Processo di pubblicazione
Comitato editoriale
Ambito e politiche
Revisione paritaria
Domande frequenti
Invia

Personale delle biblioteche

Panoramica
Testimonianze
Abbonamenti
Accesso
Risorse
Comitato consultivo della biblioteca
Domande frequenti

CHI SIAMO

Panoramica
Direzione
Blog
JoVE Help Center

Hui Xie

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Tianjin Institute of Urology

The Second Hospital of Tianjin Medical University

Economical and Efficient Protocol for Isolating and Culturing Bone Marrow-derived Dendritic Cells from Mice

Tianjin Institute of Urology